4x6t: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
''' | ==M.tuberculosis betalactamase complexed with inhibitor EC19== | ||
<StructureSection load='4x6t' size='340' side='right' caption='[[4x6t]], [[Resolution|resolution]] 1.40Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[4x6t]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X6T OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4X6T FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3Y6:3-[(2R)-2-(DIHYDROXYBORANYL)-2-{[(2R)-2-{[(4-ETHYL-2,3-DIOXO-3,4-DIHYDROPYRAZIN-1(2H)-YL)CARBONYL]AMINO}-2-(4-HYDROXYPHENYL)ACETYL]AMINO}ETHYL]BENZOIC+ACID'>3Y6</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | |||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] </span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x6t FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x6t OCA], [http://pdbe.org/4x6t PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4x6t RCSB], [http://www.ebi.ac.uk/pdbsum/4x6t PDBsum]</span></td></tr> | |||
[[Category: | </table> | ||
__TOC__ | |||
</StructureSection> | |||
[[Category: Beta-lactamase]] | |||
[[Category: Hazra, S]] | [[Category: Hazra, S]] | ||
[[Category: Beta-lactam]] | |||
[[Category: Boronate]] | |||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
[[Category: Penicillin binding protein]] | |||
[[Category: Structure based drug development]] | |||
[[Category: Transition state inhibitor]] | |||
Revision as of 15:46, 23 December 2015
M.tuberculosis betalactamase complexed with inhibitor EC19M.tuberculosis betalactamase complexed with inhibitor EC19
Structural highlights
|
| ||||||||||||||||||